BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15907835)

  • 1. PIAS proteins are involved in the SUMO-1 modification, intracellular translocation and transcriptional repressive activity of RET finger protein.
    Matsuura T; Shimono Y; Kawai K; Murakami H; Urano T; Niwa Y; Goto H; Takahashi M
    Exp Cell Res; 2005 Aug; 308(1):65-77. PubMed ID: 15907835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMOylation of RORalpha potentiates transcriptional activation function.
    Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
    Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for O-glycosylation of RFP in the interaction with enhancer of polycomb.
    Tezel G; Shimono Y; Murakumo Y; Kawai K; Fukuda T; Iwahashi N; Takahashi M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):409-14. PubMed ID: 11779184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RFP represses transcriptional activation by bHLH transcription factors.
    Bloor AJ; Kotsopoulou E; Hayward P; Champion BR; Green AR
    Oncogene; 2005 Oct; 24(45):6729-36. PubMed ID: 16007160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of SUMO-1 induces the up-regulation of heterogeneous nuclear ribonucleoprotein A2/B1 isoform B1 (hnRNP A2/B1 isoform B1) and uracil DNA glycosylase (UDG) in hepG2 cells.
    Ma KW; Au SW; Waye MM
    Cell Biochem Funct; 2009 Jun; 27(4):228-37. PubMed ID: 19384898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interaction of AIRE with PIAS1 in transcriptional regulation.
    Ilmarinen T; Kangas H; Kytömaa T; Eskelin P; Saharinen J; Seeler JS; Tanhuanpää K; Chan FY; Slattery RM; Alakurtti K; Palvimo JJ; Ulmanen I
    Mol Immunol; 2008 Apr; 45(7):1847-62. PubMed ID: 18083234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of E1AF transcriptional activity by sumoylation and PIASy.
    Nishida T; Terashima M; Fukami K; Yamada Y
    Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
    Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
    Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RET finger protein enhances MBD2- and MBD4-dependent transcriptional repression.
    Fukushige S; Kondo E; Gu Z; Suzuki H; Horii A
    Biochem Biophys Res Commun; 2006 Dec; 351(1):85-92. PubMed ID: 17049487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO modification modulates the transrepression activity of PLZF.
    Chao TT; Chang CC; Shih HM
    Biochem Biophys Res Commun; 2007 Jun; 358(2):475-82. PubMed ID: 17498654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIAS proteins as repressors of Oct4 function.
    Tolkunova E; Malashicheva A; Parfenov VN; Sustmann C; Grosschedl R; Tomilin A
    J Mol Biol; 2007 Dec; 374(5):1200-12. PubMed ID: 17991485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
    Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
    Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
    Nishida T; Yasuda H
    J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIAS1 interacts with and represses SOX9 transactivation activity.
    Oh HJ; Kido T; Lau YF
    Mol Reprod Dev; 2007 Nov; 74(11):1446-55. PubMed ID: 17440973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of STAT3 activity by Duplin, which is a negative regulator of the Wnt signal.
    Yamashina K; Yamamoto H; Chayama K; Nakajima K; Kikuchi A
    J Biochem; 2006 Feb; 139(2):305-14. PubMed ID: 16452319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation.
    Kotaja N; Aittomäki S; Silvennoinen O; Palvimo JJ; Jänne OA
    Mol Endocrinol; 2000 Dec; 14(12):1986-2000. PubMed ID: 11117529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling.
    Stehmeier P; Muller S
    Mol Cell; 2009 Feb; 33(3):400-9. PubMed ID: 19217413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression.
    Dobreva G; Dambacher J; Grosschedl R
    Genes Dev; 2003 Dec; 17(24):3048-61. PubMed ID: 14701874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin.
    Chalkiadaki A; Talianidis I
    Mol Cell Biol; 2005 Jun; 25(12):5095-105. PubMed ID: 15923626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.